91% Complication Reduction in SCS Implants Drives CompuFlo Adoption at 40+ Centers
MLSS•University of Texas Medical Branch study found CompuFlo-guided epidural access in spinal cord stimulator implantation cut odds of complications—CSF leaks, blood patches, radiculopathy—by 91% versus loss-of-resistance techniques. Clinical use now spans over 40 academic centers for epidural steroid injections, obstetric, thoracic, cervical, neuromodulation and interventional pain procedures.
1. UTMB Study Results
The recent peer-reviewed study demonstrated that CompuFlo-guided epidural access during spinal cord stimulator implantation reduced the odds of composite complications—including CSF leaks, epidural blood patches and postoperative radiculopathy—by 91% compared with conventional loss-of-resistance methods, underscoring significant safety improvements.
2. Expanded Clinical Adoption
CompuFlo systems are now deployed at more than 40 universities, academic medical centers and teaching hospitals worldwide, with growing uptake in epidural steroid injections, obstetric, thoracic and cervical epidurals, as well as chronic pain management and neuromodulation procedures.
3. Technology and Procedural Benefits
CompuFlo’s Dynamic Pressure Sensing™ technology delivers continuous real-time pressure feedback and audible alerts during needle advancement, enabling objective identification of the epidural space, enhancing procedural precision, reducing accidental dural punctures and boosting physician confidence.
